Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc.
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Day: September 20, 2021
2022 Commercial Fleet & MRO Forecast Now Available From Aviation Week Network
Over the Next Decade, Optimistic Viewpoint of Commercial Aviation’s Growth Out of the Pandemic; Airbus to Extend Lead in Narrowbody...
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Mauna Kea Technologies Announces a Capital Increase of Approximately €12.5 Million Reserved for Two Investors
This transaction by issuance of Units allows the Company to secure its financing until the end of the third quarter...